Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant to Bupivacaine in Upper Abdominal Cancer Surgery
NCT07263165Not yet recruiting
- Sponsor
- Assiut University
- Start
- Dec 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
01
Overview
Randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Total Postoperative Opioid Consumption at 24 hours. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07263165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07263165.